Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tefferi

Showing results (101-110 of 346) with videos related to

Pageof 35
Sort By:
Leukemia|December 20, 2013
Rethinking the diagnostic criteria of polycythemia veraT Barbui, J Thiele, A M Vannucchi, et al.
Bone Marrow Transplantation|March 1, 1996
Calcineurin protein phosphatase activity in peripheral blood lymphocytesF Rusnak, A H Beressi, A Haddy, et al.
Blood Cancer Journal|November 21, 2018
Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patientsN Fan, S Lavu, C A Hanson, et al.
Blood Cancer Journal|February 3, 2016
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosisT Barbui, J Thiele, A M Vannucchi, et al.
Leukemia|August 1, 1993
Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution studyM Dhodapkar, A Tefferi, J Su, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 9, 2023
Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologistR S Kuipers, L Kok, R Virmani, et al.
Leukemia|January 21, 2014
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasmsA Tefferi, J Thiele, A M Vannucchi, et al.
Leukemia|March 12, 2004
Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosisM A Elliott, A Pardanani, C Y Li, et al.
Leukemia Research|October 3, 2006
Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylateG LeMarbre, C Schinstock, R Hoyer, et al.
American Journal of Hematology|February 1, 1994
Reversible encephalopathy after cryopreserved peripheral blood stem cell infusionM Dhodapkar, S L Goldberg, A Tefferi, et al.
Pageof 35

Showing results (101-110 of 346) with videos related to

Sort By:
Pageof 35
Leukemia|December 20, 2013
Rethinking the diagnostic criteria of polycythemia veraT Barbui, J Thiele, A M Vannucchi, et al.
Bone Marrow Transplantation|March 1, 1996
Calcineurin protein phosphatase activity in peripheral blood lymphocytesF Rusnak, A H Beressi, A Haddy, et al.
Blood Cancer Journal|November 21, 2018
Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patientsN Fan, S Lavu, C A Hanson, et al.
Blood Cancer Journal|February 3, 2016
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosisT Barbui, J Thiele, A M Vannucchi, et al.
Leukemia|August 1, 1993
Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution studyM Dhodapkar, A Tefferi, J Su, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 9, 2023
Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologistR S Kuipers, L Kok, R Virmani, et al.
Leukemia|January 21, 2014
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasmsA Tefferi, J Thiele, A M Vannucchi, et al.
Leukemia|March 12, 2004
Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosisM A Elliott, A Pardanani, C Y Li, et al.
Leukemia Research|October 3, 2006
Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylateG LeMarbre, C Schinstock, R Hoyer, et al.
American Journal of Hematology|February 1, 1994
Reversible encephalopathy after cryopreserved peripheral blood stem cell infusionM Dhodapkar, S L Goldberg, A Tefferi, et al.
Pageof 35